Quest Diagnostics

Article Abstract:

Leading provider of diagnostic testing Quest Diagnostics has signed a definitive agreement to acquire the clinical laboratory operations of SmithKline Beecham PLC for about $1.3 billion in cash and stock.

United Kingdom, Asset sales & divestitures, Acquisitions & mergers, Medical laboratories, Biomedical laboratories, SmithKline Beecham PLC, DGX, Quest Diagnostics Inc. (San Juan Capistrano, California)

---

Technology and products: cardiology: PharmaNetics: coagulation therapy panel

Article Abstract:

Raleigh, NC-based PharmaNetics is tailoring their drug monitoring management to serve the needs of physicians according to CEO and president John Funkhouser.

Strategy & planning, Holding companies, not elsewhere classified, Financial Holding Companies NEC, Offices of Other Holding Companies, Financial holding companies, PharmaNetics Inc.

---

Is Abbott Laboratories moving from immunoassays to everything?

Article Abstract:

Abbott Laboratories has diversified from immunoassays and blood screenings to almost every other diagnostic market.

Expanded capacity, plant expansion, HEALTH SERVICES, Surgical and Medical Instrument Manufacturing, Surgical and medical instruments, Immunofluorescent Assay Tests, Blood Test Procedures, Brief Article, Fluorescent antibody technique, Immunologic tests, ABT, Blood tests, Abbott Laboratories (Abbott Park, Illinois)

Similar abstracts:

• Abstracts: The latest diagnostic trend: linking the point of care to the lab. Business and strategy: global standards
• Abstracts: Unique collaboration brings touching ads. Woman's Hospital
• Abstracts: Unique collaboration brings touching ads. Pat tells her story of survival through commercials
• Abstracts: Increased capacity may exacerbate rationing problems: with applications to medical care. Specialized service offerings and patients' choice of hospital: the case of cardiac catheterization
• Abstracts: Infertility: about 15% of couples may experience it. Hypertension-still searching after all those years. Allergic rhinitis: innovation opportunities are still plentiful

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.